Redhill Biopharma
RDHL
#9969
Rank
ยฃ6.62 M
Marketcap
ยฃ5.17
Share price
0.46%
Change (1 day)
-79.50%
Change (1 year)

Revenue for Redhill Biopharma (RDHL)

Revenue in 2023 (TTM): ยฃ30.62 Million

According to Redhill Biopharma's latest financial reports the company's current revenue (TTM ) is ยฃ28.43 Million. In 2022 the company made a revenue of ยฃ51.08 Million a decrease over the revenue in the year 2021 that were of ยฃ63.53 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Redhill Biopharma from 2012 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ30.62 M-40.05%
2022 ยฃ51.08 M-19.59%
2021 ยฃ63.53 M34.55%
2020 ยฃ47.21 M884.18%
2019 ยฃ4.79 M-27.16%
2018 ยฃ6.58 M122.14%
2017 ยฃ2.96 M3522.11%
2016 ยฃ0.08 M3943.37%
2015 ยฃ0 M-99.96%
2014 ยฃ4.5 M61826.69%
2013 ยฃ0 M-26.51%
2012 ยฃ0 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ42.56 B 149,591.25%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ50.26 B 176,635.21%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.02 B 112,510.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.48 B 1,608.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
ยฃ13.34 B 46,818.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel